Vertilate
Features & Advantages
Vertilate, containing 12 mg of Betahistine mesylate, offers a unique strength compared to other formulations and provides relief from vertigo and emesis by occupying specific histamine receptors in the vestibular nuclei; it is the least costly Betahistine mesylate available per weight and was specifically formulated with the average Asian build in mind, resulting in a dosage of 12 mg per tablet.
Indication
For the treatment of dizziness or a sensation of dizziness in the following: Meniere’s disease, Meniere-like syndrome and Vertigo.
Dosage & Administration
Usual adult dose is 1 tablet 3 times a day orally after each meal.
It may be lowered or raised according to the age and symptoms of patients or as prescribed by the physician.
Product Source
Philippines
Availability
Foil Strip x 10’s (Box of 100’s)
